ATTUNE Revision Knee System
Depuy Orthopaedics, Inc. · Decision date Sep 4, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on September 4, 2026 for the ATTUNE Revision Knee System, a traditional 510(k) submitted by DePuy Orthopaedics, Inc. and received June 24, 2026 under K262130. The device is classified under 21 CFR 888.3560 as a knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis, Class II, with product codes JWH and MBH; the review specialty is orthopedic.
The 510(k) summary frames the submission around manufacturing changes rather than a new device: ram extrusion as an alternative raw material consolidation method and splitting the sterilization dose into two steps, crosslinking of raw material and terminal sterilization of the finished good. The applicant states these do not affect intended use, performance, safety, effectiveness, biocompatibility, standards compliance or labeling set by the predicate. The summary does not identify the predicate device by number, so that relationship remains unverified here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 4, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262130
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Depuy Orthopaedics, Inc.
- Product code
- JWH
- Decision code
- SESE
- Decision date
- Sep 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer.
- Applicant
- Depuy Orthopaedics, Inc.
- Product code
- JWH
- FDA device class
- 2
FDA decision timeline
K262130 received
Application receipt date recorded by FDA.
K262130 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JWH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MicroPort Total Knee SystemK263065 | Suzhou Microport Orthorecon Co., Ltd. | 510(k) clearance | Oct 29, 2026 | FDA |
GMK ExtensionK262057 | Medacta International SA | 510(k) clearance | Sep 15, 2026 | FDA |
GSPE SpacerK260063 | The General Hospital Corporation, d/b/a Massachusetts | 510(k) clearance | Sep 11, 2026 | FDA |
| Suzhou Microport Orthorecon Co., Ltd. | 510(k) clearance | Sep 10, 2026 | FDA | |
| B-One Ortho, Corp. | 510(k) clearance | Sep 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Depuy Orthopaedics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Warsaw, IN
Sources and methodology
- Original FDA record: K262130
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



